Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy

Nanoparticles are commonly used in diagnostics and therapy. They are also increasingly being implemented in cancer immunotherapy because of their ability to deliver drugs and modulate the immune system. However, the effect of nanoparticles on immune cells involved in the anti-tumor immune response i...

Full description

Saved in:
Bibliographic Details
Main Authors: Lenka Rajsiglova, Michal Babic, Katerina Krausova, Pavol Lukac, Katerina Kalkusova, Pavla Taborska, Ludek Sojka, Jirina Bartunkova, Dmitry Stakheev, Luca Vannucci, Daniel Smrz
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Immunotoxicology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/1547691X.2024.2416988
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525427772850176
author Lenka Rajsiglova
Michal Babic
Katerina Krausova
Pavol Lukac
Katerina Kalkusova
Pavla Taborska
Ludek Sojka
Jirina Bartunkova
Dmitry Stakheev
Luca Vannucci
Daniel Smrz
author_facet Lenka Rajsiglova
Michal Babic
Katerina Krausova
Pavol Lukac
Katerina Kalkusova
Pavla Taborska
Ludek Sojka
Jirina Bartunkova
Dmitry Stakheev
Luca Vannucci
Daniel Smrz
author_sort Lenka Rajsiglova
collection DOAJ
description Nanoparticles are commonly used in diagnostics and therapy. They are also increasingly being implemented in cancer immunotherapy because of their ability to deliver drugs and modulate the immune system. However, the effect of nanoparticles on immune cells involved in the anti-tumor immune response is not well understood. The study reported here showed that nickel-doped maghemite nanoparticles (FN NP) are differentially cytotoxic to cultured mouse and human cancer cell lines, causing their death without negatively impacting the subsequent anticancer immune response. It also found that FN NP induced cell death in the mouse colorectal cancer cell line CT26 and human prostate cancer cell line PC-3, but not in the human prostate cancer cell line LNCaP. The induced cancer cell death did not affect the phenotype and responsivity of the isolated mouse peritoneal macrophages, or ex vivo-generated mouse bone marrow-derived, or human monocyte-derived dendritic cells. Additionally, the induced cancer cell death did not prevent the ex vivo-generated mouse or human dendritic cells from stimulating lymphocytes and enriching cell cultures with cancer cell-reactive T-cells. In conclusion, this study shows that FN NP could be a valuable platform for targeting cancer cells without causing immunosuppressive effects on the subsequent anticancer immune response.
format Article
id doaj-art-faad2b3f2a964152a6f8f1f3a094e31d
institution Kabale University
issn 1547-691X
1547-6901
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Immunotoxicology
spelling doaj-art-faad2b3f2a964152a6f8f1f3a094e31d2025-01-17T12:52:14ZengTaylor & Francis GroupJournal of Immunotoxicology1547-691X1547-69012024-12-0121110.1080/1547691X.2024.2416988Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapyLenka Rajsiglova0Michal Babic1Katerina Krausova2Pavol Lukac3Katerina Kalkusova4Pavla Taborska5Ludek Sojka6Jirina Bartunkova7Dmitry Stakheev8Luca Vannucci9Daniel Smrz10Laboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech RepublicInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech RepublicLaboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech RepublicLaboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech RepublicDepartment of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech RepublicDepartment of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech RepublicDepartment of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech RepublicDepartment of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech RepublicLaboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech RepublicLaboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech RepublicLaboratory of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech RepublicNanoparticles are commonly used in diagnostics and therapy. They are also increasingly being implemented in cancer immunotherapy because of their ability to deliver drugs and modulate the immune system. However, the effect of nanoparticles on immune cells involved in the anti-tumor immune response is not well understood. The study reported here showed that nickel-doped maghemite nanoparticles (FN NP) are differentially cytotoxic to cultured mouse and human cancer cell lines, causing their death without negatively impacting the subsequent anticancer immune response. It also found that FN NP induced cell death in the mouse colorectal cancer cell line CT26 and human prostate cancer cell line PC-3, but not in the human prostate cancer cell line LNCaP. The induced cancer cell death did not affect the phenotype and responsivity of the isolated mouse peritoneal macrophages, or ex vivo-generated mouse bone marrow-derived, or human monocyte-derived dendritic cells. Additionally, the induced cancer cell death did not prevent the ex vivo-generated mouse or human dendritic cells from stimulating lymphocytes and enriching cell cultures with cancer cell-reactive T-cells. In conclusion, this study shows that FN NP could be a valuable platform for targeting cancer cells without causing immunosuppressive effects on the subsequent anticancer immune response.https://www.tandfonline.com/doi/10.1080/1547691X.2024.2416988Nanoparticlescancer cellsimmunogenic cell deathmacrophagesdendritic cellsT-cells
spellingShingle Lenka Rajsiglova
Michal Babic
Katerina Krausova
Pavol Lukac
Katerina Kalkusova
Pavla Taborska
Ludek Sojka
Jirina Bartunkova
Dmitry Stakheev
Luca Vannucci
Daniel Smrz
Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
Journal of Immunotoxicology
Nanoparticles
cancer cells
immunogenic cell death
macrophages
dendritic cells
T-cells
title Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
title_full Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
title_fullStr Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
title_full_unstemmed Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
title_short Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
title_sort immunogenic properties of nickel doped maghemite nanoparticles and the implication for cancer immunotherapy
topic Nanoparticles
cancer cells
immunogenic cell death
macrophages
dendritic cells
T-cells
url https://www.tandfonline.com/doi/10.1080/1547691X.2024.2416988
work_keys_str_mv AT lenkarajsiglova immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT michalbabic immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT katerinakrausova immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT pavollukac immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT katerinakalkusova immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT pavlataborska immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT ludeksojka immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT jirinabartunkova immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT dmitrystakheev immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT lucavannucci immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy
AT danielsmrz immunogenicpropertiesofnickeldopedmaghemitenanoparticlesandtheimplicationforcancerimmunotherapy